Advanced Biomed (NASDAQ:ADVB) Posts Quarterly Earnings Results

Advanced Biomed (NASDAQ:ADVB) released its quarterly earnings data on Friday. The company reported $0.32 earnings per share for the quarter, Zacks reports.

Advanced Biomed Trading Up 1.1%

NASDAQ:ADVB traded up $0.00 during trading hours on Friday, reaching $0.24. The company’s stock had a trading volume of 22,968 shares, compared to its average volume of 36,709. The stock has a market capitalization of $5.20 million and a PE ratio of -1.50. Advanced Biomed has a one year low of $0.21 and a one year high of $4.10.

Analyst Ratings Changes

Separately, Weiss Ratings started coverage on shares of Advanced Biomed in a research note on Monday, January 26th. They issued a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.